Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial-Reference-Cited by-同舟云学术

Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

Published:2019-10-01 Issue:7 Volume:200 Page:857-868
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Vermeersch Kristina¹²,Gabrovska Maria³,Aumann Joseph⁴,Demedts Ingel K.⁵,Corhay Jean-Louis⁶,Marchand Eric⁷⁸,Slabbynck Hans⁹,Haenebalcke Christel¹⁰,Haerens Michiel¹¹,Hanon Shane¹²,Jordens Paul¹³,Peché Rudi¹⁴,Fremault Antoine¹⁵,Lauwerier Tine¹⁶,Delporte Anja¹⁷,Vandenberk Bert¹⁸,Willems Rik¹⁸,Everaerts Stephanie¹²,Belmans Ann¹⁹²⁰,Bogaerts Kris¹⁹²⁰,Verleden Geert M.¹²,Troosters Thierry¹²¹,Ninane Vincent³,Brusselle Guy G.¹⁷,Janssens Wim¹²

Affiliation:

1. Laboratory of Respiratory Diseases, Department of Chronic Diseases, Metabolism and Ageing

2. Department of Respiratory Diseases and

3. Department of Pneumology, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium

4. Department of Pneumology, Jessa Ziekenhuis, Hasselt, Belgium

5. Department of Respiratory Medicine, AZ Delta Roeselare-Menen, Roeselare, Belgium

6. Department of Pneumology, Centre Hospitalier Universitaire, Liège, Belgium

7. Department of Pneumology, CHU-UCL-Namur, Yvoir, Belgium

8. Faculty of Medicine, NARILIS, Laboratory of Respiratory Physiology, University of Namur, Namur, Belgium

9. Department of Respiratory Medicine, ZNA Middelheim, Antwerpen, Belgium

10. Department of Pneumology, AZ Sint-Jan, Brugge-Oostende, Belgium

11. Department of Pneumology, AZ Groeninge, Kortrijk, Belgium

12. Department of Pneumology, UZ Brussel, Jette, Belgium

13. Department of Pneumology, Onze-Lieve-Vrouw Ziekenhuis, Aalst, Belgium

14. Department of Pneumology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium

15. Department of Pneumology, Grand Hôpital de Charleroi, Charleroi, Belgium

16. Department of Pneumology, Imelda Ziekenhuis, Bonheiden, Belgium

17. Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; and

18. Department of Cardiology, University Hospitals Leuven, Leuven, Belgium

19. I-BioStat, and

20. Universiteit Hasselt, Hasselt, Belgium

21. Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven, Leuven, Belgium

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201901-0094OC

Reference35 articles.

1. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit

2. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach

3. Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines

4. Hospital management of acute exacerbations of chronic obstructive pulmonary disease

5. Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease: Don’t Shortchange Noninvasive Ventilation

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Mnemonic for Management of Stable Chronic Obstructive Pulmonary Disease: A Canadian Approach;The Journal for Nurse Practitioners;2024-09

2. Prevalence of bias attributable to composite outcome in clinical trials: a systematic review;2024-07-18

3. The role of gut-lung axis in COPD: Pathogenesis, immune response, and prospective treatment;Heliyon;2024-05

4. New insights into the pathophysiology and epidemiology of COPD exacerbations;COPD in the 21st Century;2024-03-01

5. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients;ERJ Open Research;2024-01